Reviva Pharmaceuticals Holdings Inc. announced an amendment to its bylaws, reducing the quorum required for stockholder meetings from a majority to one-third of the voting power of outstanding shares. This change allows business to be conducted at meetings with a lower threshold of shareholder participation.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reviva Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-029951), on September 26, 2025, and is solely responsible for the information contained therein.